Clinical Trial Detail

NCT ID NCT04103879
Title US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ExCellThera inc.
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

myelodysplastic syndrome

chronic myeloid leukemia

Therapies

ECT-001 cord blood cells

Cyclophosphamide + Fludarabine + Thiotepa

Tacrolimus

Cyclophosphamide + Fludarabine

Mycophenolate mofetil

Age Groups: senior adult

No variant requirements are available.